K. Tsuboi

发表

Nonhematopoietic mesenchymal stem cells can be mobilized and differentiate into cardiomyocytes after myocardial infarction.

H. Okano, Y. Matsuzaki, Y. Ikeda, 2004, Blood.

A case of clonally distinct relapse of Burkitt lymphoma 9 years after complete remission

K. Ando, N. Nakamura, M. Yabe, 2015, International Journal of Hematology.

Phase I Clinical Trial of Intravenous L-ascorbic Acid Following Salvage Chemotherapy for Relapsed B-cell non-Hodgkin's Lymphoma.

K. Ando, M. Onizuka, Hiroyuki Kobayashi, 2014, The Tokai journal of experimental and clinical medicine.

Erratum to: Successful bypass surgery for esophageal carcinoma under adequate factor XIII/13 replacement therapy in a case of intractable autoimmune hemorrhaphilia due to anti-Factor XIII/13 antibodies

K. Ando, S. Ozawa, A. Ichinose, 2016, International Journal of Hematology.

Successful bypass surgery for esophageal carcinoma under adequate factor XIII/13 replacement therapy in a case of intractable autoimmune hemorrhaphilia due to anti-Factor XIII/13 antibodies

K. Ando, S. Ozawa, A. Ichinose, 2015, International Journal of Hematology.

differentiate into cardiomyocytes after myocardial infarction Nonhematopoietic mesenchymal stem cells can be mobilized and

H. Okano, Y. Matsuzaki, Y. Ikeda, 2012 .

A novel aberrant form of e13a2 BCR-ABL1 transcript in chronic myelogenous leukemia undetectable with the standardized real-time quantitative polymerase chain reaction from the Europe Against Cancer Program

Miki L. Yamamoto, K. Ando, S. Arakawa, 2009, Clinical chemistry and laboratory medicine.

[Granulocytic sarcoma of the prostate presenting with urinary obstruction which progressed to acute myeloid leukemia].

K. Ando, N. Nakamura, K. Ohmachi, 2008, [Rinsho ketsueki] The Japanese journal of clinical hematology.

Identification of a novel SEPT9-ABL1 fusion gene in a patient with T-cell prolymphocytic leukemia

K. Ando, H. Matsuzawa, H. Kawada, 2014, Leukemia research reports.

Three cases of bortezomib-resistant multiple myeloma with extramedullary masses.

K. Ando, N. Nakamura, K. Ohmachi, 2010, The Tokai journal of experimental and clinical medicine.

Potential and origin of the hematopoietic population in human skeletal muscle.

K. Ando, S. Kato, J. Mochida, 2005, Leukemia research.

Preferential hypermethylation of the Dickkopf‐1 promoter in core‐binding factor leukaemia

K. Ando, A. Shintani, M. Onizuka, 2007, British journal of haematology.

Phase 2 study of arsenic trioxide followed by autologous hematopoietic cell transplantation for relapsed acute promyelocytic leukemia.

T. Naoe, M. Taniwaki, N. Emi, 2013, Blood.

A Phase I study to assess the safety, pharmacokinetics and efficacy of barasertib (AZD1152), an Aurora B kinase inhibitor, in Japanese patients with advanced acute myeloid leukemia.

T. Yamauchi, K. Tobinai, N. Uike, 2011, Leukemia research.

Secondary pulmonary alveolar proteinosis in a patient with chronic myeloid leukemia in the accelerated phase.

K. Ando, M. Komatsu, N. Kumaki, 2008, The Tokai journal of experimental and clinical medicine.

Intensified consolidation therapy with dose-escalated doxorubicin did not improve the prognosis of adults with acute lymphoblastic leukemia: the JALSG-ALL97 study

T. Naoe, T. Kyo, S. Horiike, 2010, International journal of hematology.

Prognostic significance ofFLT3 internal tandem duplication andNPM1 mutations in acute myeloid leukemia in an unselected patient population

K. Ando, A. Shintani, M. Onizuka, 2007 .

Infrequent hypermethylation of WIF-1 promoter in BCR/ABL-negative myeloproliferative disorders.

K. Ando, M. Onizuka, M. Shimada, 2007, The Tokai journal of experimental and clinical medicine.

An Acceptable Incidence of Infusion Site Reactions after Subcutaneous Bortezomib Administration in the Upper Arm in Japanese Patients with Multiple Myeloma

Hiroki Numata, T. Sasao, K. Tsuboi, 2014, Acta Haematologica.